Tricia Lemieux, BS
Focus on lurasidone: A new atypical antipsychotic for the treatment of schizophrenia
Lurasidone, a new-generation atypical antipsychotic, has been approved by FDA for the treatment of schizophrenia and is under investigation for the treatment of bipolar disorder. This article will discuss the clinical pharmacology, clinical trials, adverse events, drug interactions, dosing and administration, and formulary considerations.

Poll